TY - JOUR
T1 - Raman molecular imaging of brain frozen tissue sections
AU - Kast, Rachel E.
AU - Auner, Gregory W.
AU - Rosenblum, Mark L.
AU - Mikkelsen, Tom
AU - Yurgelevic, Sally M.
AU - Raghunathan, Aditya
AU - Poisson, Laila M.
AU - Kalkanis, Steven N.
N1 - Funding Information:
Funding This work was partially funded by the Hermelin Brain Tumor Center at Henry Ford Hospital, the Smart Sensors and Integrated Microsystems Program at Wayne State University, and the Paul U. Strauss/TEAMS endowed chair position at Wayne State University.
Publisher Copyright:
© 2014, Springer Science+Business Media New York.
PY - 2014/9/27
Y1 - 2014/9/27
N2 - Raman spectroscopy provides a molecular signature of the region being studied. It is ideal for neurosurgical applications because it is non-destructive, label-free, not impacted by water concentration, and can map an entire region of tissue. The objective of this paper is to demonstrate the meaningful spatial molecular information provided by Raman spectroscopy for identification of regions of normal brain, necrosis, diffusely infiltrating glioma and solid glioblastoma (GBM). Five frozen section tissues (1 normal, 1 necrotic, 1 GBM, and 2 infiltrating glioma) were mapped in their entirety using a 300-µm-square step size. Smaller regions of interest were also mapped using a 25-µm step size. The relative concentrations of relevant biomolecules were mapped across all tissues and compared with adjacent hematoxylin and eosin-stained sections, allowing identification of normal, GBM, and necrotic regions. Raman peaks and peak ratios mapped included 1003, 1313, 1431, 1585, and 1659 cm−1. Tissue maps identified boundaries of grey and white matter, necrosis, GBM, and infiltrating tumor. Complementary information, including relative concentration of lipids, protein, nucleic acid, and hemoglobin, was presented in a manner which can be easily adapted for in vivo tissue mapping. Raman spectroscopy can successfully provide label-free imaging of tissue characteristics with high accuracy. It can be translated to a surgical or laboratory tool for rapid, non-destructive imaging of tumor margins.
AB - Raman spectroscopy provides a molecular signature of the region being studied. It is ideal for neurosurgical applications because it is non-destructive, label-free, not impacted by water concentration, and can map an entire region of tissue. The objective of this paper is to demonstrate the meaningful spatial molecular information provided by Raman spectroscopy for identification of regions of normal brain, necrosis, diffusely infiltrating glioma and solid glioblastoma (GBM). Five frozen section tissues (1 normal, 1 necrotic, 1 GBM, and 2 infiltrating glioma) were mapped in their entirety using a 300-µm-square step size. Smaller regions of interest were also mapped using a 25-µm step size. The relative concentrations of relevant biomolecules were mapped across all tissues and compared with adjacent hematoxylin and eosin-stained sections, allowing identification of normal, GBM, and necrotic regions. Raman peaks and peak ratios mapped included 1003, 1313, 1431, 1585, and 1659 cm−1. Tissue maps identified boundaries of grey and white matter, necrosis, GBM, and infiltrating tumor. Complementary information, including relative concentration of lipids, protein, nucleic acid, and hemoglobin, was presented in a manner which can be easily adapted for in vivo tissue mapping. Raman spectroscopy can successfully provide label-free imaging of tissue characteristics with high accuracy. It can be translated to a surgical or laboratory tool for rapid, non-destructive imaging of tumor margins.
KW - Glioblastoma
KW - Necrosis
KW - Raman imaging
KW - Raman spectroscopy
UR - http://www.scopus.com/inward/record.url?scp=84910135646&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84910135646&partnerID=8YFLogxK
U2 - 10.1007/s11060-014-1536-9
DO - 10.1007/s11060-014-1536-9
M3 - Article
C2 - 25038847
AN - SCOPUS:84910135646
SN - 0167-594X
VL - 120
SP - 55
EP - 62
JO - Journal of Neuro-Oncology
JF - Journal of Neuro-Oncology
IS - 1
ER -